Sumitomo Mitsui Trust Holdings Inc. Invests $18.68 Million in Celsius Holdings, Inc. (NASDAQ:CELH)

Sumitomo Mitsui Trust Holdings Inc. acquired a new stake in shares of Celsius Holdings, Inc. (NASDAQ:CELH - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm acquired 342,558 shares of the company's stock, valued at approximately $18,676,000. Sumitomo Mitsui Trust Holdings Inc. owned approximately 0.15% of Celsius as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also recently made changes to their positions in the stock. Moody National Bank Trust Division bought a new position in shares of Celsius during the 4th quarter valued at $917,000. Kercheville Advisors LLC bought a new position in shares of Celsius during the 4th quarter valued at $851,000. Qube Research & Technologies Ltd grew its holdings in shares of Celsius by 761.1% during the 3rd quarter. Qube Research & Technologies Ltd now owns 190,048 shares of the company's stock valued at $32,612,000 after purchasing an additional 167,977 shares during the last quarter. Arizona State Retirement System grew its holdings in shares of Celsius by 190.0% during the 4th quarter. Arizona State Retirement System now owns 41,209 shares of the company's stock valued at $2,247,000 after purchasing an additional 26,998 shares during the last quarter. Finally, Pacer Advisors Inc. grew its holdings in shares of Celsius by 396.9% during the 4th quarter. Pacer Advisors Inc. now owns 26,438 shares of the company's stock valued at $1,441,000 after purchasing an additional 21,117 shares during the last quarter. Hedge funds and other institutional investors own 60.95% of the company's stock.

Celsius Stock Up 3.2 %

Shares of CELH traded up $2.24 during trading hours on Tuesday, reaching $72.03. 5,327,430 shares of the company traded hands, compared to its average volume of 4,754,670. The company's fifty day moving average price is $79.01 and its two-hundred day moving average price is $64.43. The company has a market capitalization of $16.64 billion, a price-to-earnings ratio of 90.25, a price-to-earnings-growth ratio of 2.01 and a beta of 1.86. Celsius Holdings, Inc. has a 12 month low of $29.91 and a 12 month high of $99.62.

Celsius (NASDAQ:CELH - Get Free Report) last announced its earnings results on Thursday, February 29th. The company reported $0.17 earnings per share for the quarter, beating analysts' consensus estimates of $0.16 by $0.01. The firm had revenue of $347.44 million for the quarter, compared to analyst estimates of $326.77 million. Celsius had a net margin of 17.21% and a return on equity of 131.58%. The company's revenue for the quarter was up 95.2% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.01 EPS. On average, analysts expect that Celsius Holdings, Inc. will post 1.09 EPS for the current year.

Wall Street Analysts Forecast Growth

CELH has been the topic of several recent research reports. Stifel Europe increased their target price on shares of Celsius from $90.00 to $95.00 and gave the company a "buy" rating in a report on Monday, March 18th. Stifel Nicolaus increased their target price on shares of Celsius from $67.00 to $90.00 and gave the company a "buy" rating in a report on Friday, March 1st. Piper Sandler increased their target price on shares of Celsius from $76.00 to $90.00 and gave the company an "overweight" rating in a report on Friday, March 1st. Maxim Group raised their price target on shares of Celsius from $100.00 to $110.00 and gave the stock a "buy" rating in a report on Monday, April 1st. Finally, UBS Group raised their price target on shares of Celsius from $73.00 to $99.00 and gave the stock a "buy" rating in a report on Friday, March 1st. Two analysts have rated the stock with a hold rating and twelve have given a buy rating to the company's stock. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $85.10.

Insider Activity

In related news, major shareholder Deborah Desantis sold 128,309 shares of Celsius stock in a transaction dated Wednesday, January 24th. The shares were sold at an average price of $43.96, for a total transaction of $5,640,463.64. Following the completion of the transaction, the insider now directly owns 31,096,560 shares of the company's stock, valued at approximately $1,367,004,777.60. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. In related news, major shareholder Deborah Desantis sold 128,309 shares of Celsius stock in a transaction dated Wednesday, January 24th. The shares were sold at an average price of $43.96, for a total transaction of $5,640,463.64. Following the completion of the transaction, the insider now directly owns 31,096,560 shares of the company's stock, valued at approximately $1,367,004,777.60. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, Director Nicholas Castaldo sold 165,000 shares of Celsius stock in a transaction dated Monday, March 4th. The shares were sold at an average price of $83.33, for a total transaction of $13,749,450.00. Following the transaction, the director now directly owns 352,864 shares of the company's stock, valued at $29,404,157.12. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 908,742 shares of company stock valued at $54,790,179. Corporate insiders own 2.20% of the company's stock.

Celsius Profile

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.